Appendix 1—figure 12. Cumulative seroprevalence estimated with 95% credible intervals (ribbons) using three different methods to calculate the time-to-seroreversion distribution.

For the analyses in this paper, we consider the seroprevalence curve in green, obtained using repeat donors to estimate the time to seroreversion.